These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36119411)

  • 1. Adaptation of a Public-Private Partnership Model for the Implementation of Minipool Nucleic Acid Testing for Screening Routine Blood Donations and Assay Evaluation.
    Mahapatra S; Parida P; Prasad CR; Palai S; Mishra D; Behera S; Mishra RK; Prusty BP; Sarkar K
    J Lab Physicians; 2022 Sep; 14(3):317-323. PubMed ID: 36119411
    [No Abstract]   [Full Text] [Related]  

  • 2. Nucleic acid testing for blood banks: an experience from a tertiary care centre in New Delhi, India.
    Agarwal N; Chatterjee K; Coshic P; Borgohain M
    Transfus Apher Sci; 2013 Dec; 49(3):482-4. PubMed ID: 23541414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test.
    Kleinman SH; Strong DM; Tegtmeier GG; Holland PV; Gorlin JB; Cousins C; Chiacchierini RP; Pietrelli LA
    Transfusion; 2005 Aug; 45(8):1247-57. PubMed ID: 16078909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routine screening of blood donations at Qingdao central blood bank, China, for hepatitis B virus (HBV) DNA with a real-time, multiplex nucleic acid test for HBV, hepatitis C virus, and human immunodeficiency virus Types 1 and 2.
    Yang Z; Xu L; Liu L; Feng Q; Zhang L; Ma W; Saldanha J; Wang M; Zhao L
    Transfusion; 2013 Oct; 53(10 Pt 2):2538-44. PubMed ID: 23480568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus testing by minipool nucleic acid testing: does it improve blood safety?
    Stramer SL; Notari EP; Krysztof DE; Dodd RY
    Transfusion; 2013 Oct; 53(10 Pt 2):2449-58. PubMed ID: 23607261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of blood donor screening by HIV, HCV, HBV-NAT assays, as well as HBsAg and anti-HBc immunoassays in Germany (2008-2015).
    Fiedler SA; Oberle D; Chudy M; Scheiblauer H; Henseler O; Halbauer J; Heiden M; Funk M
    Vox Sang; 2019 Jul; 114(5):443-450. PubMed ID: 31012114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Trends in residual risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2002 and impact of viral genome screening (Nucleic Acid Testing)].
    Pillonel J; Laperche S; ; ;
    Transfus Clin Biol; 2004 Apr; 11(2):81-6. PubMed ID: 15120104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of Adopting Nucleic Acid Amplification Technique for Blood Donor Screening in a Resource Limited Setting: A Study from a Single Centre in South India.
    Ranganathan S; Iyer RN; Balakrishna N
    Indian J Hematol Blood Transfus; 2022 Jul; 38(3):571-576. PubMed ID: 35747563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Background rate of low-level HCV RNA in anti-HCV confirmed-positive and minipool nucleic acid test-nonreactive blood donations.
    Groves JA; Y Dodd R; Zhu X; Linnen JM; Stramer SL
    Transfusion; 2022 Jan; 62(1):143-150. PubMed ID: 34888879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot study on screening blood donors with individual-donation nucleic acid testing in China.
    Dong J; Wu Y; Zhu H; Li G; Lv M; Wu D; Li X; Zhu F; Lv H
    Blood Transfus; 2014 Apr; 12(2):172-9. PubMed ID: 24333061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of nucleic acid testing to detect human immunodeficiency virus, hepatitis C virus, and hepatitis B virus yields from a single blood center in China with 10-years review.
    Wu D; Feng F; Wang X; Wang D; Hu Y; Yu Y; Huang J; Wang M; Dong J; Wu Y; Zhu H; Zhu F
    BMC Infect Dis; 2022 Mar; 22(1):279. PubMed ID: 35321684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?
    Busch MP
    Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
    Li L; Chen PJ; Chen MH; Chak KF; Lin KS; Tsai SJ
    Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?
    Stramer SL; Zou S; Notari EP; Foster GA; Krysztof DE; Musavi F; Dodd RY
    Transfusion; 2012 Feb; 52(2):440-6. PubMed ID: 21810101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window-phase donations not detected by NAT.
    Weusten JJ; van Drimmelen HA; Lelie PN
    Transfusion; 2002 May; 42(5):537-48. PubMed ID: 12084161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automated nucleic acid amplification testing in blood banks: An additional layer of blood safety.
    Chigurupati P; Murthy KS
    Asian J Transfus Sci; 2015; 9(1):9-11. PubMed ID: 25722565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is the meaning of a nonresolved viral nucleic acid test-reactive minipool?
    Wang L; Chang L; Xie Y; Huang C; Xu L; Qian R; Zhu H; He Y; Li J; Huang H; Li W; Zhang K; Zhang R; Xie J; Sun Y; Li J
    Transfusion; 2015 Feb; 55(2):395-404. PubMed ID: 25125223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of Using Nucleic Acid Amplification Test to Screen Blood Donors for Hepatitis B, Hepatitis C, and HIV: A Tertiary Care Hospital Experience From Pakistan.
    Ali SM; Raza N; Irfan M; Mohammad MF; Kazmi FH; Fatima Z
    Cureus; 2023 Jan; 15(1):e34216. PubMed ID: 36852365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individual donor-nucleic acid testing for human immunodeficiency virus-1, hepatitis C virus and hepatitis B virus and its role in blood safety.
    Kumar R; Gupta S; Kaur A; Gupta M
    Asian J Transfus Sci; 2015; 9(2):199-202. PubMed ID: 26420945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the NucliSens Extractor combined with the AmpliScreen HIV version 1.5 and HCV version 2.0 test for application in NAT minipool screening.
    Jongerius JM; Sjerps M; Cuijpers HT; van Drimmelen HA; van der Poel CL; Reesink HW; Molijn MH; Peeters GA; Peeters TP; Lelie PN
    Transfusion; 2002 Jun; 42(6):792-7. PubMed ID: 12147034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.